Clinical trial
External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes
NCT05537662 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 6, 2023
- Completion date
- April 30, 2025
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.